Millar, Inc. is a leading developer and manufacturer of pressure sensor-enabled devices, partnering with global leaders in technology, manufacturing, and healthcare to transform breakthrough technologies into life-saving medical innovations. Founded in 1969 by Huntly Millar, the company pioneered the development of catheter-based, solid-state pressure sensors, focusing on integrating this technology into catheters for life sciences and clinical applications. Millar's mission is to push the limits of pressure sensor technology to advance medical understanding and enable new scientific discoveries, continuously improving human health.
Strategically, Millar emphasizes the integration of Micro-Electro-Mechanical Systems (MEMS) pressure sensors into medical devices, offering Original Equipment Manufacturer (OEM) solutions that facilitate rapid time-to-market and cost savings. The company's core objectives include delivering precise, real-time measurements through their pressure sensor technology, which is utilized in benchtop testing, clinical trials, and as a bridge to OEM medical device innovation. Millar targets the medical device and life sciences industries, focusing on applications that require accurate pressure measurements for improved patient outcomes.
In August 2023, Millar inaugurated a state-of-the-art 56,000-square-foot headquarters and manufacturing facility in Pearland's Lower Kirby District, Texas. This facility houses approximately 140 employees and consolidates the company's research and development, manufacturing, and warehousing operations. The move was facilitated through a partnership with the Pearland Economic Development Corporation and city officials, reflecting Millar's commitment to growth and innovation.
Millar's technological platform is distinguished by its expertise in MEMS pressure sensor integration, ISO 13485 precision manufacturing, and wireless pressure technology. The company's proprietary technologies include catheter-based, solid-state pressure sensors known for their low drift and high accuracy. Significant scientific methods employed by Millar encompass the development of pressure-volume loop systems and high-fidelity pressure catheters, which are essential tools in cardiovascular research and diagnosis.
The leadership team at Millar is spearheaded by CEO Tim Daugherty, who has been instrumental in guiding the company's strategic direction and fostering a culture of innovation. Under his leadership, Millar has achieved recognition as one of Houston's Top Workplaces in 2019 and 2021, reflecting the company's commitment to employee engagement and development.
In the competitive landscape, Millar faces competition from companies such as Midmark, UFP Technologies, SPS, and Penumbra. Midmark and UFP Technologies are known for their medical device manufacturing capabilities, while Penumbra specializes in designing and developing medical devices. Millar differentiates itself through its specialized focus on MEMS pressure sensor technology and its extensive experience in integrating these sensors into medical devices.
Millar has established significant collaborations and partnerships to enhance its market position and innovation capacity. For instance, the company has partnered with Codman, now part of Integra LifeSciences, to develop the Codman Microsensor® ICP Transducer, revolutionizing the measurement of intracranial pressure in patients with traumatic brain injury.
Strategically, Millar is well-positioned to capitalize on opportunities for expansion in the medical device and life sciences markets. The company's strengths in MEMS pressure sensor integration, combined with its commitment to innovation and quality, provide a solid foundation for future growth and the development of new medical technologies.